Rigel Pharmaceuticals | RIGL - Ação





Ação Alterar Data
Amgen USD 6.19B 39M 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.57B 13M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 14.53B 785M 2026-03
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
MacroGenics USD 9.5M 1.59M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Pfizer USD 10.67B 13M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Veracyte USD 21.42M 870K 2026-03